Quoted:
Selective Plaque Clearance
Cyclarity Therapeutics has presented new data supporting its small molecule approach to cardiovascular disease, targeting damaged atherosclerotic plaque directly. The therapy is designed to bind and remove 7-ketocholesterol, a toxic oxidized cholesterol linked to inflammation and plaque instability in arterial walls.
Link to full video on YouTube:
▶Video · YouTube · Longevity.TechnologyLongevity.Technology UNLOCKEDLongevity.Technology UNLOCKED brings together science, business, and human potential to explore the frontier of longer, healthier living. 🎙 Mondays: In-depth...m.youtube.com
#reverseHD #7ketocholesterolHD #cyclaritytherapeuticsHD
